Brad L. Tade

CIK 2030561 · View on SEC EDGAR ↗

Insider

First SEC filing: July 26, 2024 · Latest: July 26, 2024

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 8 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

8 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 22, 2024 ADMA S 15,000 $21.15 $317,250 199,433 Direct -7.00% Disposed -53.1% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 19, 2025 ADMA Stock Option (right to buy) Common Stock (93,023) $16.07 Feb. 19, 2035 93,023 Acquired
July 24, 2024 ADMA Stock Option (right to buy) Common Stock (115,100) $13.58 July 24, 2034 115,100 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
July 26, 2024 ADMA Common Stock Direct
July 26, 2024 ADMA Restricted Stock Units→ Common Stock (75,000) 75,000 Direct
July 26, 2024 ADMA Restricted Stock Units→ Common Stock (50,000) 50,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $500,000 $250,000 $73,645 $2,823,630
2024 $374,792 $1,253,192 $1,002,292 $254,475 $51,684 $2,936,435

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.